

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.34043519 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.01897827 |
| 3 | vocalization behavior (GO:0071625) | 4.93337421 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.91619685 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.88492966 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.75407827 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.70144932 |
| 8 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.68155014 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.65102640 |
| 10 | locomotory exploration behavior (GO:0035641) | 4.61947249 |
| 11 | glutamate secretion (GO:0014047) | 4.59721624 |
| 12 | regulation of synapse structural plasticity (GO:0051823) | 4.46199490 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.35836725 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.24865641 |
| 15 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.21603969 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.20657821 |
| 17 | protein localization to synapse (GO:0035418) | 4.14001931 |
| 18 | glutamate receptor signaling pathway (GO:0007215) | 3.94724800 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 3.89364233 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 3.87366014 |
| 21 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.85437631 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 3.84998148 |
| 23 | neuronal action potential propagation (GO:0019227) | 3.82757718 |
| 24 | activation of protein kinase A activity (GO:0034199) | 3.81389424 |
| 25 | cell communication by electrical coupling (GO:0010644) | 3.80142725 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.79131537 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.79006047 |
| 28 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.72135529 |
| 29 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.70134056 |
| 30 | membrane depolarization during action potential (GO:0086010) | 3.69933434 |
| 31 | neurotransmitter secretion (GO:0007269) | 3.69450014 |
| 32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.69084402 |
| 33 | response to peptidoglycan (GO:0032494) | 3.68300281 |
| 34 | cellular potassium ion homeostasis (GO:0030007) | 3.67952806 |
| 35 | neuron-neuron synaptic transmission (GO:0007270) | 3.67160327 |
| 36 | * sensory perception of smell (GO:0007608) | 3.66698248 |
| 37 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.63540088 |
| 38 | detection of calcium ion (GO:0005513) | 3.61908753 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.60396857 |
| 40 | long-term memory (GO:0007616) | 3.59171689 |
| 41 | exploration behavior (GO:0035640) | 3.58469026 |
| 42 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.55307268 |
| 43 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.52295507 |
| 44 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.51062962 |
| 45 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.50948416 |
| 46 | negative regulation of interleukin-12 production (GO:0032695) | 3.50722698 |
| 47 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.50554362 |
| 48 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.49113576 |
| 49 | sodium ion export (GO:0071436) | 3.48557620 |
| 50 | positive regulation of synapse maturation (GO:0090129) | 3.43118314 |
| 51 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.42166148 |
| 52 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.41996270 |
| 53 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.41281777 |
| 54 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.41206605 |
| 55 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.40590445 |
| 56 | negative regulation of cell killing (GO:0031342) | 3.39889289 |
| 57 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.39889289 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.33630043 |
| 59 | regulation of membrane repolarization (GO:0060306) | 3.33478967 |
| 60 | regulation of postsynaptic membrane potential (GO:0060078) | 3.31928254 |
| 61 | regulation of cell communication by electrical coupling (GO:0010649) | 3.29767231 |
| 62 | positive regulation of membrane potential (GO:0045838) | 3.27598132 |
| 63 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.23470955 |
| 64 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.23086650 |
| 65 | regulation of synaptic plasticity (GO:0048167) | 3.22270908 |
| 66 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.22040765 |
| 67 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.21845155 |
| 68 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.19814542 |
| 69 | gamma-aminobutyric acid transport (GO:0015812) | 3.19706527 |
| 70 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.17362482 |
| 71 | layer formation in cerebral cortex (GO:0021819) | 3.17229335 |
| 72 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.16810774 |
| 73 | dendritic spine morphogenesis (GO:0060997) | 3.16279770 |
| 74 | membrane depolarization (GO:0051899) | 3.14839575 |
| 75 | cell communication involved in cardiac conduction (GO:0086065) | 3.13402640 |
| 76 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.12433076 |
| 77 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.12267384 |
| 78 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.11693247 |
| 79 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.11342163 |
| 80 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.10935210 |
| 81 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.10935210 |
| 82 | glycine transport (GO:0015816) | 3.10748366 |
| 83 | potassium ion import (GO:0010107) | 3.10351861 |
| 84 | protein localization to endosome (GO:0036010) | 3.10091339 |
| 85 | proline transport (GO:0015824) | 3.09562575 |
| 86 | positive regulation of neurotransmitter transport (GO:0051590) | 3.08351069 |
| 87 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.07713977 |
| 88 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.07464290 |
| 89 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06284428 |
| 90 | regulation of neurotransmitter secretion (GO:0046928) | 3.05960403 |
| 91 | neuron recognition (GO:0008038) | 3.05674334 |
| 92 | neurotransmitter transport (GO:0006836) | 3.04737742 |
| 93 | transmission of nerve impulse (GO:0019226) | 3.02128749 |
| 94 | synaptic vesicle endocytosis (GO:0048488) | 3.00118796 |
| 95 | positive regulation by symbiont of host defense response (GO:0052509) | 3.00008512 |
| 96 | modulation by symbiont of host defense response (GO:0052031) | 3.00008512 |
| 97 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.00008512 |
| 98 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.00008512 |
| 99 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.00008512 |
| 100 | modulation by symbiont of host immune response (GO:0052553) | 3.00008512 |
| 101 | regulation of early endosome to late endosome transport (GO:2000641) | 2.98141584 |
| 102 | behavioral response to cocaine (GO:0048148) | 2.97615654 |
| 103 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.96345372 |
| 104 | germinal center formation (GO:0002467) | 2.96305514 |
| 105 | barbed-end actin filament capping (GO:0051016) | 2.95660892 |
| 106 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.95315652 |
| 107 | cardiac muscle contraction (GO:0060048) | 2.94991777 |
| 108 | long-term synaptic potentiation (GO:0060291) | 2.94008759 |
| 109 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.92446869 |
| 110 | striatum development (GO:0021756) | 2.92222155 |
| 111 | NIK/NF-kappaB signaling (GO:0038061) | 2.91759623 |
| 112 | regulation of vesicle fusion (GO:0031338) | 2.91341894 |
| 113 | regulation of synapse maturation (GO:0090128) | 2.91006412 |
| 114 | response to acidic pH (GO:0010447) | 2.88485922 |
| 115 | positive regulation of type 2 immune response (GO:0002830) | 2.85175281 |
| 116 | regulation of neurotransmitter transport (GO:0051588) | 2.84452748 |
| 117 | auditory behavior (GO:0031223) | 2.84066464 |
| 118 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.83659289 |
| 119 | myeloid dendritic cell differentiation (GO:0043011) | 2.83433907 |
| 120 | synaptic transmission (GO:0007268) | 2.83091925 |
| 121 | regulation of neurotransmitter levels (GO:0001505) | 2.81328216 |
| 122 | regulation of ARF protein signal transduction (GO:0032012) | 2.81234652 |
| 123 | behavioral fear response (GO:0001662) | 2.81220781 |
| 124 | behavioral defense response (GO:0002209) | 2.81220781 |
| 125 | positive regulation of dendritic spine development (GO:0060999) | 2.81104459 |
| 126 | regulation of dendritic spine development (GO:0060998) | 2.81022280 |
| 127 | plasma membrane repair (GO:0001778) | 2.80486942 |
| 128 | neuromuscular process controlling balance (GO:0050885) | 2.80261057 |
| 129 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.79861996 |
| 130 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.77657666 |
| 131 | adenosine receptor signaling pathway (GO:0001973) | 2.77570622 |
| 132 | response to muramyl dipeptide (GO:0032495) | 2.76720792 |
| 133 | regulation of mast cell degranulation (GO:0043304) | 2.73394808 |
| 134 | T-helper 1 type immune response (GO:0042088) | 2.68603056 |
| 135 | mannose metabolic process (GO:0006013) | 2.67201839 |
| 136 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.66638982 |
| 137 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.62878427 |
| 138 | virion attachment to host cell (GO:0019062) | 2.61266290 |
| 139 | adhesion of symbiont to host cell (GO:0044650) | 2.61266290 |
| 140 | positive regulation of protein dephosphorylation (GO:0035307) | 2.60815901 |
| 141 | neutrophil activation involved in immune response (GO:0002283) | 2.60688374 |
| 142 | activation of MAPKKK activity (GO:0000185) | 2.59212676 |
| 143 | L-amino acid import (GO:0043092) | 2.59124269 |
| 144 | regulation of leukocyte degranulation (GO:0043300) | 2.58325932 |
| 145 | stress fiber assembly (GO:0043149) | 2.57856214 |
| 146 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.56960123 |
| 147 | positive regulation of mast cell degranulation (GO:0043306) | 2.56253063 |
| 148 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.56253063 |
| 149 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.56131139 |
| 150 | response to thyroid hormone (GO:0097066) | 2.55643876 |
| 151 | regulation of type 2 immune response (GO:0002828) | 2.52777963 |
| 152 | glycosphingolipid catabolic process (GO:0046479) | 2.52075044 |
| 153 | positive regulation of mast cell activation (GO:0033005) | 2.48099309 |
| 154 | myeloid cell activation involved in immune response (GO:0002275) | 2.45129522 |
| 155 | modulation by symbiont of host cellular process (GO:0044068) | 2.44920285 |
| 156 | regulation of regulated secretory pathway (GO:1903305) | 2.44503994 |
| 157 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44415949 |
| 158 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.43177034 |
| 159 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.42148881 |
| 160 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.41736433 |
| 161 | regulation of mononuclear cell migration (GO:0071675) | 2.40735838 |
| 162 | cortical actin cytoskeleton organization (GO:0030866) | 2.39867342 |
| 163 | regulation of chemokine biosynthetic process (GO:0045073) | 2.38769458 |
| 164 | regulation of podosome assembly (GO:0071801) | 2.36022989 |
| 165 | positive regulation of leukocyte degranulation (GO:0043302) | 2.35776057 |
| 166 | amino acid import (GO:0043090) | 2.33862763 |
| 167 | regulation of vitamin metabolic process (GO:0030656) | 2.33393032 |
| 168 | adhesion of symbiont to host (GO:0044406) | 2.32330202 |
| 169 | positive regulation of fibroblast migration (GO:0010763) | 2.30719193 |
| 170 | response to laminar fluid shear stress (GO:0034616) | 2.30691584 |
| 171 | regulation of gamma-delta T cell activation (GO:0046643) | 2.29893949 |
| 172 | regulation of macrophage cytokine production (GO:0010935) | 2.29287161 |
| 173 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.27540993 |
| 174 | signal complex assembly (GO:0007172) | 2.27368899 |
| 175 | macrophage activation (GO:0042116) | 2.26124324 |
| 176 | myeloid dendritic cell activation (GO:0001773) | 2.25336142 |
| 177 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.25328492 |
| 178 | regulation of ARF GTPase activity (GO:0032312) | 2.24444168 |
| 179 | regulation of macrophage chemotaxis (GO:0010758) | 2.24104366 |
| 180 | immunoglobulin mediated immune response (GO:0016064) | 2.23671650 |
| 181 | glycolipid catabolic process (GO:0019377) | 2.23172520 |
| 182 | detection of molecule of bacterial origin (GO:0032490) | 2.23103240 |
| 183 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.22771873 |
| 184 | response to nerve growth factor (GO:1990089) | 2.22771873 |
| 185 | positive regulation of heat generation (GO:0031652) | 2.20753960 |
| 186 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.20443029 |
| 187 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.20421154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.87334807 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.41020084 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.32086720 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 3.01470968 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.82535273 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.80981651 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73536163 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.71494442 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.61336717 |
| 10 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.59873144 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.56464954 |
| 12 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.49125874 |
| 13 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.49125874 |
| 14 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.48256006 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38573924 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37428016 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.35988800 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.32491343 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.28670840 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.20885094 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.20020231 |
| 22 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.17003176 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13534073 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.12633842 |
| 25 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11447954 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.10828479 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09844531 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.09166811 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.08444134 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.03721176 |
| 31 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.02741014 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00985396 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.00883206 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00281187 |
| 35 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.97534757 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93810473 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90511620 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.87514548 |
| 39 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85588248 |
| 40 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.84881130 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81629974 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.79215051 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.77563783 |
| 44 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.75871360 |
| 45 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74673185 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73844141 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72705748 |
| 48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.70987026 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69710690 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69336389 |
| 51 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.66968769 |
| 52 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65264849 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63905460 |
| 54 | * MYC_22102868_ChIP-Seq_BL_Human | 1.59901342 |
| 55 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.58072628 |
| 56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57895386 |
| 57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.56680363 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56364243 |
| 59 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55759628 |
| 60 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55047060 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.54648391 |
| 62 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52608487 |
| 63 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.51136365 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51008262 |
| 65 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50912271 |
| 66 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48444725 |
| 67 | MAF_26560356_Chip-Seq_TH1_Human | 1.47424382 |
| 68 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44737487 |
| 69 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.44645149 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40694257 |
| 71 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39329626 |
| 72 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38930764 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38614756 |
| 74 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.38268055 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37678485 |
| 76 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36835618 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36570570 |
| 78 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.36526452 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36489232 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.35869305 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35605149 |
| 82 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33440522 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32297751 |
| 84 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31574059 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30866666 |
| 86 | * P68_20966046_ChIP-Seq_HELA_Human | 1.30570865 |
| 87 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30545728 |
| 88 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30225130 |
| 89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.29863127 |
| 90 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28710311 |
| 91 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28392130 |
| 92 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26601118 |
| 93 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25602166 |
| 94 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24954515 |
| 95 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23326857 |
| 96 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22858851 |
| 97 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22345833 |
| 98 | * MAF_26560356_Chip-Seq_TH2_Human | 1.20880102 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20295408 |
| 100 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19067744 |
| 101 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.19018057 |
| 102 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19003483 |
| 103 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18783299 |
| 104 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.18516928 |
| 105 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18432897 |
| 106 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17963287 |
| 107 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16713613 |
| 108 | AR_19668381_ChIP-Seq_PC3_Human | 1.16113277 |
| 109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16017262 |
| 110 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15990652 |
| 111 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14595840 |
| 112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14487394 |
| 113 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.14235478 |
| 114 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14100198 |
| 115 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13880055 |
| 116 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13828679 |
| 117 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13442780 |
| 118 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13228828 |
| 119 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.12527122 |
| 120 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11558280 |
| 121 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11033129 |
| 122 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09853003 |
| 123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09548355 |
| 124 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.09464155 |
| 125 | P300_19829295_ChIP-Seq_ESCs_Human | 1.09194211 |
| 126 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08695713 |
| 127 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08543952 |
| 128 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.08468660 |
| 129 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07508991 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07051830 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05414137 |
| 132 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05377846 |
| 133 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04638161 |
| 134 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04139769 |
| 135 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03554837 |
| 136 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.03377904 |
| 137 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03280838 |
| 138 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01299683 |
| 139 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00501305 |
| 140 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00167089 |
| 141 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99984149 |
| 142 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99777225 |
| 143 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98909526 |
| 144 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98903321 |
| 145 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98843806 |
| 146 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98663572 |
| 147 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98626684 |
| 148 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98509265 |
| 149 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98338978 |
| 150 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98237544 |
| 151 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98171003 |
| 152 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98095709 |
| 153 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97544672 |
| 154 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97507136 |
| 155 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97210063 |
| 156 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.95397593 |
| 157 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94940144 |
| 158 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94334624 |
| 159 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93117604 |
| 160 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93117604 |
| 161 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92933347 |
| 162 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92348072 |
| 163 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92246149 |
| 164 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90620268 |
| 165 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89490200 |
| 166 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89450125 |
| 167 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87812301 |
| 168 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87030683 |
| 169 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85703003 |
| 170 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85629434 |
| 171 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.84737996 |
| 172 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84518643 |
| 173 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.84377042 |
| 174 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83834631 |
| 175 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83577678 |
| 176 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83376919 |
| 177 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81665872 |
| 178 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81155552 |
| 179 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.80558911 |
| 180 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.77827904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.90474550 |
| 2 | MP0003880_abnormal_central_pattern | 4.39581360 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.74709957 |
| 4 | MP0003303_peritoneal_inflammation | 3.60867695 |
| 5 | MP0001984_abnormal_olfaction | 3.22438644 |
| 6 | MP0009745_abnormal_behavioral_response | 3.09822751 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.09242406 |
| 8 | MP0006082_CNS_inflammation | 3.01619590 |
| 9 | MP0003436_decreased_susceptibility_to | 3.00611561 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.99367612 |
| 11 | MP0000751_myopathy | 2.92072656 |
| 12 | MP0002064_seizures | 2.91350748 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.91003143 |
| 14 | MP0004270_analgesia | 2.86165399 |
| 15 | MP0009046_muscle_twitch | 2.84510813 |
| 16 | MP0002822_catalepsy | 2.80100905 |
| 17 | MP0003646_muscle_fatigue | 2.78493297 |
| 18 | MP0005451_abnormal_body_composition | 2.58425857 |
| 19 | MP0002272_abnormal_nervous_system | 2.47804411 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.45127050 |
| 21 | MP0001486_abnormal_startle_reflex | 2.36675486 |
| 22 | MP0004215_abnormal_myocardial_fiber | 2.35112424 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.31476694 |
| 24 | MP0009840_abnormal_foam_cell | 2.29911786 |
| 25 | MP0005423_abnormal_somatic_nervous | 2.28518944 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.24141060 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.19102316 |
| 28 | MP0000604_amyloidosis | 2.12923302 |
| 29 | MP0002734_abnormal_mechanical_nocicepti | 2.11955257 |
| 30 | MP0005000_abnormal_immune_tolerance | 2.08247715 |
| 31 | MP0005671_abnormal_response_to | 2.05894475 |
| 32 | MP0002419_abnormal_innate_immunity | 2.05051962 |
| 33 | MP0003690_abnormal_glial_cell | 2.04544431 |
| 34 | MP0003300_gastrointestinal_ulcer | 2.02732442 |
| 35 | MP0009785_altered_susceptibility_to | 2.00310295 |
| 36 | MP0001790_abnormal_immune_system | 1.97725456 |
| 37 | MP0005387_immune_system_phenotype | 1.97725456 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.94528673 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.92651029 |
| 40 | MP0009278_abnormal_bone_marrow | 1.89769206 |
| 41 | MP0000343_altered_response_to | 1.85734996 |
| 42 | MP0003724_increased_susceptibility_to | 1.83824847 |
| 43 | MP0008569_lethality_at_weaning | 1.83248135 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.82653839 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.80485467 |
| 46 | MP0005025_abnormal_response_to | 1.79687295 |
| 47 | MP0004084_abnormal_cardiac_muscle | 1.79192555 |
| 48 | MP0002735_abnormal_chemical_nociception | 1.79085686 |
| 49 | MP0002736_abnormal_nociception_after | 1.77932757 |
| 50 | MP0002067_abnormal_sensory_capabilities | 1.73957103 |
| 51 | MP0004036_abnormal_muscle_relaxation | 1.72307178 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.69927073 |
| 53 | MP0005166_decreased_susceptibility_to | 1.65530842 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 1.64305322 |
| 55 | MP0000749_muscle_degeneration | 1.63531238 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.63239797 |
| 57 | MP0001970_abnormal_pain_threshold | 1.62221132 |
| 58 | MP0000685_abnormal_immune_system | 1.61745510 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.58879135 |
| 60 | MP0003137_abnormal_impulse_conducting | 1.58442585 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.57072311 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.56582931 |
| 63 | MP0004947_skin_inflammation | 1.54813190 |
| 64 | MP0002184_abnormal_innervation | 1.54556942 |
| 65 | MP0002723_abnormal_immune_serum | 1.52695807 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.49910669 |
| 67 | MP0004924_abnormal_behavior | 1.49910669 |
| 68 | MP0002557_abnormal_social/conspecific_i | 1.49174475 |
| 69 | MP0004085_abnormal_heartbeat | 1.48806074 |
| 70 | MP0004811_abnormal_neuron_physiology | 1.48649679 |
| 71 | MP0002452_abnormal_antigen_presenting | 1.48528732 |
| 72 | MP0004233_abnormal_muscle_weight | 1.45461924 |
| 73 | MP0004484_altered_response_of | 1.43807031 |
| 74 | MP0009780_abnormal_chondrocyte_physiolo | 1.41979715 |
| 75 | MP0008260_abnormal_autophagy | 1.41692094 |
| 76 | MP0003329_amyloid_beta_deposits | 1.39881771 |
| 77 | MP0003191_abnormal_cellular_cholesterol | 1.39497442 |
| 78 | MP0002733_abnormal_thermal_nociception | 1.38203747 |
| 79 | MP0001800_abnormal_humoral_immune | 1.38165089 |
| 80 | MP0004510_myositis | 1.37847237 |
| 81 | MP0003879_abnormal_hair_cell | 1.37345730 |
| 82 | MP0001348_abnormal_lacrimal_gland | 1.36003938 |
| 83 | MP0004858_abnormal_nervous_system | 1.32774380 |
| 84 | MP0000778_abnormal_nervous_system | 1.32204336 |
| 85 | MP0005620_abnormal_muscle_contractility | 1.31744882 |
| 86 | MP0004142_abnormal_muscle_tone | 1.31455321 |
| 87 | MP0003828_pulmonary_edema | 1.30512571 |
| 88 | MP0005330_cardiomyopathy | 1.28505058 |
| 89 | MP0001853_heart_inflammation | 1.28350274 |
| 90 | MP0003279_aneurysm | 1.27686366 |
| 91 | MP0002420_abnormal_adaptive_immunity | 1.27234713 |
| 92 | MP0001819_abnormal_immune_cell | 1.26786983 |
| 93 | MP0002066_abnormal_motor_capabilities/c | 1.24573882 |
| 94 | MP0002882_abnormal_neuron_morphology | 1.24161622 |
| 95 | MP0002254_reproductive_system_inflammat | 1.23560008 |
| 96 | MP0009764_decreased_sensitivity_to | 1.23385911 |
| 97 | MP0003633_abnormal_nervous_system | 1.21235798 |
| 98 | MP0004087_abnormal_muscle_fiber | 1.20653632 |
| 99 | MP0003448_altered_tumor_morphology | 1.20530872 |
| 100 | MP0002405_respiratory_system_inflammati | 1.19939296 |
| 101 | MP0001529_abnormal_vocalization | 1.19045553 |
| 102 | MP0002972_abnormal_cardiac_muscle | 1.18758576 |
| 103 | MP0005310_abnormal_salivary_gland | 1.17294028 |
| 104 | MP0000955_abnormal_spinal_cord | 1.16299016 |
| 105 | MP0001958_emphysema | 1.16274844 |
| 106 | MP0001502_abnormal_circadian_rhythm | 1.16204618 |
| 107 | MP0000858_altered_metastatic_potential | 1.15969518 |
| 108 | MP0004130_abnormal_muscle_cell | 1.15905897 |
| 109 | MP0003091_abnormal_cell_migration | 1.13849498 |
| 110 | MP0006276_abnormal_autonomic_nervous | 1.13076988 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 1.12025443 |
| 112 | MP0002106_abnormal_muscle_physiology | 1.11401611 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 1.09023985 |
| 114 | MP0000747_muscle_weakness | 1.08075238 |
| 115 | MP0001905_abnormal_dopamine_level | 1.06917640 |
| 116 | MP0001845_abnormal_inflammatory_respons | 1.06783723 |
| 117 | MP0001545_abnormal_hematopoietic_system | 1.03830794 |
| 118 | MP0005397_hematopoietic_system_phenotyp | 1.03830794 |
| 119 | MP0008438_abnormal_cutaneous_collagen | 1.01756888 |
| 120 | MP0005551_abnormal_eye_electrophysiolog | 1.01017775 |
| 121 | MP0003787_abnormal_imprinting | 1.00556388 |
| 122 | MP0003631_nervous_system_phenotype | 1.00278012 |
| 123 | MP0005410_abnormal_fertilization | 1.00266294 |
| 124 | MP0008775_abnormal_heart_ventricle | 0.97986321 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.97792463 |
| 126 | MP0008469_abnormal_protein_level | 0.96980746 |
| 127 | MP0002269_muscular_atrophy | 0.96956829 |
| 128 | MP0008874_decreased_physiological_sensi | 0.96751141 |
| 129 | MP0005369_muscle_phenotype | 0.96169944 |
| 130 | MP0003656_abnormal_erythrocyte_physiolo | 0.94680935 |
| 131 | MP0008004_abnormal_stomach_pH | 0.93824440 |
| 132 | MP0003453_abnormal_keratinocyte_physiol | 0.93804478 |
| 133 | MP0000759_abnormal_skeletal_muscle | 0.93431169 |
| 134 | MP0002229_neurodegeneration | 0.93010749 |
| 135 | MP0001188_hyperpigmentation | 0.92092621 |
| 136 | MP0005394_taste/olfaction_phenotype | 0.91926862 |
| 137 | MP0005499_abnormal_olfactory_system | 0.91926862 |
| 138 | MP0002152_abnormal_brain_morphology | 0.91125323 |
| 139 | MP0005623_abnormal_meninges_morphology | 0.89474962 |
| 140 | MP0002877_abnormal_melanocyte_morpholog | 0.88161485 |
| 141 | MP0010155_abnormal_intestine_physiology | 0.87725494 |
| 142 | MP0005535_abnormal_body_temperature | 0.86508642 |
| 143 | MP0000716_abnormal_immune_system | 0.86040305 |
| 144 | MP0005390_skeleton_phenotype | 0.85475373 |
| 145 | MP0005165_increased_susceptibility_to | 0.85441232 |
| 146 | MP0008961_abnormal_basal_metabolism | 0.84827690 |
| 147 | MP0006138_congestive_heart_failure | 0.84670683 |
| 148 | MP0005666_abnormal_adipose_tissue | 0.83624992 |
| 149 | MP0003075_altered_response_to | 0.82746581 |
| 150 | MP0002933_joint_inflammation | 0.80875766 |
| 151 | MP0005670_abnormal_white_adipose | 0.80177685 |
| 152 | MP0001542_abnormal_bone_strength | 0.79763947 |
| 153 | MP0000733_abnormal_muscle_development | 0.79551991 |
| 154 | MP0001544_abnormal_cardiovascular_syste | 0.79143580 |
| 155 | MP0005385_cardiovascular_system_phenoty | 0.79143580 |
| 156 | MP0004885_abnormal_endolymph | 0.78735043 |
| 157 | MP0000013_abnormal_adipose_tissue | 0.75181306 |
| 158 | MP0002069_abnormal_eating/drinking_beha | 0.73950529 |
| 159 | MP0002332_abnormal_exercise_endurance | 0.72862336 |
| 160 | MP0002090_abnormal_vision | 0.71865000 |
| 161 | MP0003634_abnormal_glial_cell | 0.71082104 |
| 162 | MP0001485_abnormal_pinna_reflex | 0.70108108 |
| 163 | MP0008872_abnormal_physiological_respon | 0.69744127 |
| 164 | MP0000920_abnormal_myelination | 0.69697285 |
| 165 | MP0002752_abnormal_somatic_nervous | 0.69246225 |
| 166 | MP0005409_darkened_coat_color | 0.62466277 |
| 167 | MP0010630_abnormal_cardiac_muscle | 0.62382436 |
| 168 | MP0000750_abnormal_muscle_regeneration | 0.62033288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.82161555 |
| 2 | Myokymia (HP:0002411) | 5.52299063 |
| 3 | Focal seizures (HP:0007359) | 5.11651211 |
| 4 | Visual hallucinations (HP:0002367) | 4.71187309 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.52621357 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.52621357 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 4.52621357 |
| 8 | Sudden death (HP:0001699) | 4.52297264 |
| 9 | Febrile seizures (HP:0002373) | 4.42410951 |
| 10 | Atonic seizures (HP:0010819) | 4.35522402 |
| 11 | Epileptic encephalopathy (HP:0200134) | 4.25655300 |
| 12 | Exercise-induced myalgia (HP:0003738) | 3.83971849 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.78758981 |
| 14 | Atrial fibrillation (HP:0005110) | 3.76699423 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.75102029 |
| 16 | Bundle branch block (HP:0011710) | 3.71614222 |
| 17 | Primary atrial arrhythmia (HP:0001692) | 3.65732863 |
| 18 | Absence seizures (HP:0002121) | 3.64340849 |
| 19 | Ventricular fibrillation (HP:0001663) | 3.63009704 |
| 20 | Syncope (HP:0001279) | 3.58338822 |
| 21 | Prolonged QT interval (HP:0001657) | 3.58069501 |
| 22 | Calf muscle hypertrophy (HP:0008981) | 3.48732492 |
| 23 | Generalized tonic-clonic seizures (HP:0002069) | 3.47488187 |
| 24 | Supraventricular tachycardia (HP:0004755) | 3.47401633 |
| 25 | Dialeptic seizures (HP:0011146) | 3.42101862 |
| 26 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.36783708 |
| 27 | Supraventricular arrhythmia (HP:0005115) | 3.36524424 |
| 28 | Abnormality of macrophages (HP:0004311) | 3.33940022 |
| 29 | Dysostosis multiplex (HP:0000943) | 3.28270399 |
| 30 | Neuronal loss in central nervous system (HP:0002529) | 3.25641839 |
| 31 | Abnormal EKG (HP:0003115) | 3.15514887 |
| 32 | Cerebral inclusion bodies (HP:0100314) | 3.14963152 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 3.12522584 |
| 34 | Broad-based gait (HP:0002136) | 3.04826998 |
| 35 | Gaze-evoked nystagmus (HP:0000640) | 3.04762860 |
| 36 | Asymmetric septal hypertrophy (HP:0001670) | 3.03771302 |
| 37 | Dysmetric saccades (HP:0000641) | 3.03506324 |
| 38 | Axonal loss (HP:0003447) | 3.02577462 |
| 39 | Loss of speech (HP:0002371) | 3.01561545 |
| 40 | Systemic lupus erythematosus (HP:0002725) | 2.99300462 |
| 41 | Genetic anticipation (HP:0003743) | 2.98106225 |
| 42 | Depression (HP:0000716) | 2.91259266 |
| 43 | Abnormality of the calf musculature (HP:0001430) | 2.88945495 |
| 44 | Dysdiadochokinesis (HP:0002075) | 2.88729799 |
| 45 | Poor eye contact (HP:0000817) | 2.82745355 |
| 46 | Dysmetria (HP:0001310) | 2.77738399 |
| 47 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.77673673 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.77266327 |
| 49 | Type 1 muscle fiber predominance (HP:0003803) | 2.76921567 |
| 50 | Anxiety (HP:0000739) | 2.76268455 |
| 51 | Postural instability (HP:0002172) | 2.73933577 |
| 52 | Hyperventilation (HP:0002883) | 2.73415702 |
| 53 | Apathy (HP:0000741) | 2.73197350 |
| 54 | Action tremor (HP:0002345) | 2.70976028 |
| 55 | Ankle clonus (HP:0011448) | 2.70353396 |
| 56 | Exercise-induced muscle cramps (HP:0003710) | 2.68951532 |
| 57 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.68924550 |
| 58 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.68867193 |
| 59 | Retinal dysplasia (HP:0007973) | 2.64074292 |
| 60 | Supranuclear gaze palsy (HP:0000605) | 2.62906668 |
| 61 | Distal lower limb muscle weakness (HP:0009053) | 2.60222966 |
| 62 | Central scotoma (HP:0000603) | 2.60186510 |
| 63 | Heart block (HP:0012722) | 2.60101735 |
| 64 | Impaired social interactions (HP:0000735) | 2.59274154 |
| 65 | Abnormal social behavior (HP:0012433) | 2.59274154 |
| 66 | Eczematoid dermatitis (HP:0000976) | 2.58137083 |
| 67 | Myotonia (HP:0002486) | 2.57498767 |
| 68 | Obstructive sleep apnea (HP:0002870) | 2.57221503 |
| 69 | Muscle fiber inclusion bodies (HP:0100299) | 2.56933059 |
| 70 | Diminished motivation (HP:0000745) | 2.56895662 |
| 71 | Ventricular arrhythmia (HP:0004308) | 2.52895211 |
| 72 | Nemaline bodies (HP:0003798) | 2.52807464 |
| 73 | Nuclear cataract (HP:0100018) | 2.52189798 |
| 74 | Truncal ataxia (HP:0002078) | 2.47949587 |
| 75 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.46482357 |
| 76 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45998367 |
| 77 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45998367 |
| 78 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45998367 |
| 79 | Increased connective tissue (HP:0009025) | 2.41920473 |
| 80 | Disinhibition (HP:0000734) | 2.40271026 |
| 81 | Distal lower limb amyotrophy (HP:0008944) | 2.39649199 |
| 82 | Left ventricular hypertrophy (HP:0001712) | 2.39018417 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.38709642 |
| 84 | Recurrent bacterial skin infections (HP:0005406) | 2.36333265 |
| 85 | Abnormal atrioventricular conduction (HP:0005150) | 2.36134431 |
| 86 | Absent/shortened dynein arms (HP:0200106) | 2.35625955 |
| 87 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.35625955 |
| 88 | Recurrent abscess formation (HP:0002722) | 2.33893756 |
| 89 | Progressive inability to walk (HP:0002505) | 2.33454465 |
| 90 | Ventricular tachycardia (HP:0004756) | 2.30515919 |
| 91 | Mucopolysacchariduria (HP:0008155) | 2.30259732 |
| 92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.30259732 |
| 93 | Amblyopia (HP:0000646) | 2.27370594 |
| 94 | Lower limb amyotrophy (HP:0007210) | 2.26555663 |
| 95 | Amyloidosis (HP:0011034) | 2.26466815 |
| 96 | Torticollis (HP:0000473) | 2.26382456 |
| 97 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.26058218 |
| 98 | Orchitis (HP:0100796) | 2.26028456 |
| 99 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.25906486 |
| 100 | Mutism (HP:0002300) | 2.25357120 |
| 101 | Muscle fiber splitting (HP:0003555) | 2.24493932 |
| 102 | EMG: myopathic abnormalities (HP:0003458) | 2.23475077 |
| 103 | Peripheral hypomyelination (HP:0007182) | 2.23206010 |
| 104 | Atrioventricular block (HP:0001678) | 2.23031290 |
| 105 | Pheochromocytoma (HP:0002666) | 2.21462935 |
| 106 | Palpitations (HP:0001962) | 2.20629315 |
| 107 | Slow saccadic eye movements (HP:0000514) | 2.20207782 |
| 108 | Urinary urgency (HP:0000012) | 2.19718668 |
| 109 | Stomatitis (HP:0010280) | 2.18462023 |
| 110 | Mediastinal lymphadenopathy (HP:0100721) | 2.17058031 |
| 111 | Abnormality of the nasal mucosa (HP:0000433) | 2.16994111 |
| 112 | Impaired smooth pursuit (HP:0007772) | 2.16698579 |
| 113 | Myositis (HP:0100614) | 2.15243869 |
| 114 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.15083219 |
| 115 | Subaortic stenosis (HP:0001682) | 2.15083219 |
| 116 | Difficulty running (HP:0009046) | 2.14784037 |
| 117 | Hemiplegia (HP:0002301) | 2.13623131 |
| 118 | Optic neuritis (HP:0100653) | 2.13603452 |
| 119 | Retrobulbar optic neuritis (HP:0100654) | 2.13603452 |
| 120 | Abnormality of the lower motor neuron (HP:0002366) | 2.13069654 |
| 121 | Rapidly progressive (HP:0003678) | 2.11528517 |
| 122 | Limb dystonia (HP:0002451) | 2.10824181 |
| 123 | Myopathic facies (HP:0002058) | 2.07918000 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 2.07614070 |
| 125 | Hemiparesis (HP:0001269) | 2.06655516 |
| 126 | Focal dystonia (HP:0004373) | 2.06215961 |
| 127 | Hyporeflexia of lower limbs (HP:0002600) | 2.05925998 |
| 128 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.03899916 |
| 129 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.03687026 |
| 130 | Distal upper limb amyotrophy (HP:0007149) | 2.03462538 |
| 131 | Upper limb amyotrophy (HP:0009129) | 2.03462538 |
| 132 | Tetraplegia (HP:0002445) | 2.02837882 |
| 133 | Abnormal eating behavior (HP:0100738) | 2.02091599 |
| 134 | Abnormality of binocular vision (HP:0011514) | 2.01659900 |
| 135 | Diplopia (HP:0000651) | 2.01659900 |
| 136 | Bradykinesia (HP:0002067) | 2.01603871 |
| 137 | Absent speech (HP:0001344) | 2.00860539 |
| 138 | Scanning speech (HP:0002168) | 1.98871552 |
| 139 | Vertebral compression fractures (HP:0002953) | 1.97153058 |
| 140 | Bradycardia (HP:0001662) | 1.96851946 |
| 141 | Dementia (HP:0000726) | 1.96762940 |
| 142 | Achilles tendon contracture (HP:0001771) | 1.96621410 |
| 143 | Spastic gait (HP:0002064) | 1.96605163 |
| 144 | Frequent falls (HP:0002359) | 1.95974890 |
| 145 | Abnormal gallbladder physiology (HP:0012438) | 1.95659771 |
| 146 | Cholecystitis (HP:0001082) | 1.95659771 |
| 147 | Impaired vibratory sensation (HP:0002495) | 1.92485426 |
| 148 | Increased variability in muscle fiber diameter (HP:0003557) | 1.91995476 |
| 149 | Cerebral aneurysm (HP:0004944) | 1.91493620 |
| 150 | Rigidity (HP:0002063) | 1.91303811 |
| 151 | Neuroendocrine neoplasm (HP:0100634) | 1.90978935 |
| 152 | Epileptiform EEG discharges (HP:0011182) | 1.90974091 |
| 153 | Excessive salivation (HP:0003781) | 1.90366844 |
| 154 | Drooling (HP:0002307) | 1.90366844 |
| 155 | Personality changes (HP:0000751) | 1.88867772 |
| 156 | Spondylolisthesis (HP:0003302) | 1.88581808 |
| 157 | Stereotypic behavior (HP:0000733) | 1.88556435 |
| 158 | Myoglobinuria (HP:0002913) | 1.88483966 |
| 159 | Upper motor neuron abnormality (HP:0002127) | 1.88345041 |
| 160 | Inability to walk (HP:0002540) | 1.88211685 |
| 161 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88142613 |
| 162 | Lower limb muscle weakness (HP:0007340) | 1.87254787 |
| 163 | Delusions (HP:0000746) | 1.85010641 |
| 164 | Lipoatrophy (HP:0100578) | 1.84303252 |
| 165 | Craniofacial dystonia (HP:0012179) | 1.83195207 |
| 166 | Interstitial pulmonary disease (HP:0006530) | 1.83029169 |
| 167 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.82756575 |
| 168 | Purpura (HP:0000979) | 1.82661022 |
| 169 | Abnormality of saccadic eye movements (HP:0000570) | 1.82473103 |
| 170 | Chronic obstructive pulmonary disease (HP:0006510) | 1.81995427 |
| 171 | Obstructive lung disease (HP:0006536) | 1.81995427 |
| 172 | Myocardial infarction (HP:0001658) | 1.80257678 |
| 173 | Increased serum ferritin (HP:0003281) | 1.79229621 |
| 174 | Abnormality of the periventricular white matter (HP:0002518) | 1.78769028 |
| 175 | Annular pancreas (HP:0001734) | 1.77883772 |
| 176 | Slender build (HP:0001533) | 1.77326155 |
| 177 | Bulbar palsy (HP:0001283) | 1.76810969 |
| 178 | Nasal polyposis (HP:0100582) | 1.73736727 |
| 179 | Autoimmune thrombocytopenia (HP:0001973) | 1.73211318 |
| 180 | Ulnar deviation of the wrist (HP:0003049) | 1.73089309 |
| 181 | Emphysema (HP:0002097) | 1.72817295 |
| 182 | Foot dorsiflexor weakness (HP:0009027) | 1.72776358 |
| 183 | Insomnia (HP:0100785) | 1.72509412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.39618858 |
| 2 | NTRK3 | 4.04543922 |
| 3 | IRAK3 | 2.98147445 |
| 4 | MAP3K4 | 2.67551194 |
| 5 | MAP3K9 | 2.65484885 |
| 6 | DAPK2 | 2.52450111 |
| 7 | MAP2K7 | 2.34846205 |
| 8 | PHKG1 | 2.30785434 |
| 9 | PHKG2 | 2.30785434 |
| 10 | PRKD3 | 2.29860197 |
| 11 | TAOK2 | 2.27064079 |
| 12 | PAK6 | 2.14844396 |
| 13 | DDR2 | 2.14485397 |
| 14 | MINK1 | 2.10698830 |
| 15 | MAP3K11 | 2.09541988 |
| 16 | MARK1 | 2.07143612 |
| 17 | MAP3K14 | 1.97429451 |
| 18 | TESK1 | 1.93584401 |
| 19 | ERN1 | 1.82602998 |
| 20 | CASK | 1.73181996 |
| 21 | MAP2K3 | 1.72910837 |
| 22 | NTRK2 | 1.68008824 |
| 23 | CAMKK1 | 1.62761968 |
| 24 | RIPK4 | 1.60911526 |
| 25 | MAP2K4 | 1.60692946 |
| 26 | STK38 | 1.60617496 |
| 27 | DAPK1 | 1.60118064 |
| 28 | TRIB3 | 1.59909579 |
| 29 | PRPF4B | 1.59583758 |
| 30 | DMPK | 1.54177592 |
| 31 | TNIK | 1.53363124 |
| 32 | MAP3K12 | 1.45817515 |
| 33 | CDK19 | 1.44495394 |
| 34 | PINK1 | 1.43324341 |
| 35 | BLK | 1.41730584 |
| 36 | MOS | 1.40429733 |
| 37 | FES | 1.40149843 |
| 38 | LATS2 | 1.40008971 |
| 39 | PLK2 | 1.39238620 |
| 40 | TBK1 | 1.37894110 |
| 41 | CDK5 | 1.37648733 |
| 42 | NME2 | 1.37185935 |
| 43 | MAPK13 | 1.36308095 |
| 44 | MAP3K1 | 1.35460107 |
| 45 | TYK2 | 1.31514126 |
| 46 | SIK2 | 1.31257764 |
| 47 | LMTK2 | 1.30832108 |
| 48 | MAP3K3 | 1.27420625 |
| 49 | CAMK1 | 1.23697311 |
| 50 | ARAF | 1.23216697 |
| 51 | TTN | 1.22308643 |
| 52 | GRK5 | 1.21905378 |
| 53 | KSR2 | 1.21143713 |
| 54 | PDK4 | 1.20495222 |
| 55 | PDK3 | 1.20495222 |
| 56 | CAMK2A | 1.19752663 |
| 57 | MATK | 1.19515590 |
| 58 | PRKCG | 1.17279182 |
| 59 | CAMK2D | 1.14697096 |
| 60 | MAP4K1 | 1.14457775 |
| 61 | CAMK2B | 1.12510736 |
| 62 | PTK2B | 1.08544510 |
| 63 | CSK | 1.07119029 |
| 64 | JAK1 | 1.05741323 |
| 65 | PAK3 | 1.04679151 |
| 66 | MARK2 | 1.03635921 |
| 67 | SIK3 | 1.02152657 |
| 68 | SIK1 | 0.99433028 |
| 69 | FGR | 0.97978535 |
| 70 | MUSK | 0.96305704 |
| 71 | ZAP70 | 0.92415657 |
| 72 | TESK2 | 0.91612536 |
| 73 | CAMKK2 | 0.91066722 |
| 74 | PNCK | 0.88835324 |
| 75 | TGFBR2 | 0.88834972 |
| 76 | KSR1 | 0.88789456 |
| 77 | TAOK1 | 0.88146650 |
| 78 | PDGFRA | 0.87257953 |
| 79 | PRKCH | 0.86133048 |
| 80 | ICK | 0.84451274 |
| 81 | CAMK1G | 0.84317337 |
| 82 | NTRK1 | 0.84050105 |
| 83 | SGK223 | 0.83840309 |
| 84 | SGK494 | 0.83840309 |
| 85 | UHMK1 | 0.82822832 |
| 86 | BMPR2 | 0.82579645 |
| 87 | STK11 | 0.81867889 |
| 88 | MAP3K7 | 0.80175927 |
| 89 | OBSCN | 0.79208661 |
| 90 | SGK2 | 0.78887749 |
| 91 | RIPK1 | 0.78842831 |
| 92 | DAPK3 | 0.78033935 |
| 93 | MAPK7 | 0.77542861 |
| 94 | PDK1 | 0.76820980 |
| 95 | CAMK2G | 0.76775145 |
| 96 | CAMK4 | 0.76010800 |
| 97 | MAP3K13 | 0.75963898 |
| 98 | NEK1 | 0.75075099 |
| 99 | CDC42BPA | 0.74181111 |
| 100 | PDPK1 | 0.73948843 |
| 101 | TYRO3 | 0.73683813 |
| 102 | MYLK | 0.73680313 |
| 103 | TNK2 | 0.72148020 |
| 104 | LIMK1 | 0.71207349 |
| 105 | JAK2 | 0.70986761 |
| 106 | SGK3 | 0.70206968 |
| 107 | IRAK2 | 0.69372919 |
| 108 | BRAF | 0.68247369 |
| 109 | CDK15 | 0.67380133 |
| 110 | CDK18 | 0.67371556 |
| 111 | SGK1 | 0.67222441 |
| 112 | PRKCE | 0.67117587 |
| 113 | JAK3 | 0.66202042 |
| 114 | IRAK4 | 0.65700229 |
| 115 | PIM2 | 0.62530932 |
| 116 | MAPK12 | 0.62511028 |
| 117 | PRKD2 | 0.62326017 |
| 118 | RAF1 | 0.61091360 |
| 119 | PKN1 | 0.60196792 |
| 120 | OXSR1 | 0.60167930 |
| 121 | ABL2 | 0.59378210 |
| 122 | IKBKB | 0.59068285 |
| 123 | EEF2K | 0.58925932 |
| 124 | DYRK1A | 0.58471952 |
| 125 | CDK11A | 0.58423181 |
| 126 | CDK14 | 0.57538943 |
| 127 | SYK | 0.57409655 |
| 128 | ALK | 0.57259121 |
| 129 | MAP2K6 | 0.56645108 |
| 130 | CDK12 | 0.56478961 |
| 131 | MAPK4 | 0.55615877 |
| 132 | TIE1 | 0.53528144 |
| 133 | NME1 | 0.52831223 |
| 134 | PRKG2 | 0.52558736 |
| 135 | CSNK1G2 | 0.51403837 |
| 136 | EPHB1 | 0.51166733 |
| 137 | WNK1 | 0.50492660 |
| 138 | RPS6KA3 | 0.47192237 |
| 139 | PDK2 | 0.45272869 |
| 140 | MAP3K5 | 0.44949177 |
| 141 | GRK7 | 0.44898131 |
| 142 | SMG1 | 0.43873408 |
| 143 | HCK | 0.43565587 |
| 144 | PRKD1 | 0.43284596 |
| 145 | RET | 0.43124358 |
| 146 | MAP3K6 | 0.42613576 |
| 147 | RPS6KA2 | 0.41589484 |
| 148 | ROCK2 | 0.41203264 |
| 149 | MAPKAPK5 | 0.41152319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.79238422 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.38209097 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.88525352 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.78761934 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.59043903 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.58494207 |
| 7 | * Morphine addiction_Homo sapiens_hsa05032 | 2.49386469 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.46503307 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.31971570 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.28032482 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18317525 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.17569603 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.09148553 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.06143378 |
| 15 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.02217874 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.94502911 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.94072229 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.93105305 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.92255628 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.91296336 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86767986 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.86356333 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.84926490 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84888801 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.84396831 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.83033625 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.79713073 |
| 28 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.74723306 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72496860 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.67557311 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.67100668 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.58495238 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.54022515 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.48802692 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.48663655 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47853928 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.46580049 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46548429 |
| 39 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.43716480 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.42350900 |
| 41 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.42053216 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40585881 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.38987487 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38694955 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37272111 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.36576113 |
| 47 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36252093 |
| 48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34974930 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33368890 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 1.31662884 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31260617 |
| 52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.29756288 |
| 53 | Long-term depression_Homo sapiens_hsa04730 | 1.29621684 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.28909059 |
| 55 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.26495464 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22839843 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.18709822 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18441791 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18231499 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 1.17033401 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15724712 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15039430 |
| 63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11870947 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.07739851 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.06881359 |
| 66 | Legionellosis_Homo sapiens_hsa05134 | 1.06477562 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 1.06315504 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.04250945 |
| 69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03955530 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03860174 |
| 71 | Influenza A_Homo sapiens_hsa05164 | 1.03529766 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.02178833 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01924805 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01229392 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99559243 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98416208 |
| 77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97799415 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.97090817 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96566435 |
| 80 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94257178 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.92596545 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.92329661 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91891861 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91464329 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.91043294 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89676539 |
| 87 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88695936 |
| 88 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.88473890 |
| 89 | Shigellosis_Homo sapiens_hsa05131 | 0.87769112 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86910199 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86609516 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.84819984 |
| 93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.83632167 |
| 94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82656396 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82203373 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.81935276 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.81342391 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.81022118 |
| 99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80252522 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79819927 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.77269735 |
| 102 | Hepatitis B_Homo sapiens_hsa05161 | 0.76997386 |
| 103 | Axon guidance_Homo sapiens_hsa04360 | 0.76967052 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75615272 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75016401 |
| 106 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74254065 |
| 107 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72769369 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72131107 |
| 109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69873445 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68444311 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.66962362 |
| 112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66919977 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66727034 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66235874 |
| 115 | Measles_Homo sapiens_hsa05162 | 0.65925444 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64420221 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63840785 |
| 118 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.63347854 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.62382142 |
| 120 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60859690 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60546677 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59038444 |
| 123 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58095192 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56162583 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55542897 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54734894 |
| 127 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.54293915 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53961936 |
| 129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53847620 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53659988 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53332248 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52622322 |
| 133 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52225801 |
| 134 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52010666 |
| 135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50132631 |
| 136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49622348 |
| 137 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48066404 |
| 138 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37191653 |
| 139 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36811423 |
| 140 | Bile secretion_Homo sapiens_hsa04976 | 0.35029813 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.33746617 |
| 142 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32186849 |
| 143 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31116255 |
| 144 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30367007 |
| 145 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.29864783 |
| 146 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29083025 |
| 147 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28733123 |
| 148 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28692861 |
| 149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27599051 |
| 150 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27273199 |
| 151 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27099747 |
| 152 | Platelet activation_Homo sapiens_hsa04611 | 0.26221948 |
| 153 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25769212 |
| 154 | Alcoholism_Homo sapiens_hsa05034 | 0.25570868 |
| 155 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24621308 |

